Skip to content

Study · Measured the body's own peptide · 2008

1 result

Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin.

Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A

International archives of allergy and immunology30 Apr 2008Cited by 96 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In skin biopsies, mRNA of the body's own LL‑37 was not significantly higher in atopic dermatitis or psoriasis vulgaris patients than in controls, unlike the other antimicrobial peptides measured.

    In plain wordsSkin of people with eczema or psoriasis did not have more of the body's own LL‑37 messenger RNA than healthy skin.

    Peptide
    LL-37
    Outcome
    No significant changeLL-37 mRNA in skin, atopic dermatitis and psoriasis versus controls
    Study

    n = 95

    Comparator
    Healthy controls
    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    Except for LL-37, mRNA of hBDs, psoriasin, and RNase 7 was significantly higher expressed in AD (n = 42) and/or PV (n = 35) patients when compared to controls (n = 18).
    1 context sentence
    Summary · context
    Skin biopsies were obtained from healthy subjects and patients with AD and PV.

    This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.